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1. Introduction
Due to the high prevalence 
and complex etiology of mas-
titis in cattle is a disease that 
is difficult to treat. Mastitis ad-
versely affects the health of dairy 
cows and milk quality. Changes 
in milk composition have been 
widely studied in mastitis, but 
studies have shown [1] that gas-
trointestinal microorganisms 
also have a decisive influence on 
inflammation of other peripheral 
tissues and organs, including the 
breast [2].
The main manifestations of 
clinical mastitis are fever, red-
ness and pain of exchange, in-
filtration of inflammatory cells, 
edema of the acinar ducts, which 
leads to an increase in the num-
ber of somatic cells in milk and 
decreased milk yield [3]. On the 
contrary, subclinical mastitis 
has a latent and long incubation 
period. Although the udder of 
cows has no visible changes in 
appearance, there is an increase 
in the content of somatic cells 
and microorganisms in milk [4]. 
Mastitis on dairy farms is usually 
treated with antibiotics by veter-
inarians. However, the process 
recurs, which leads to a con-
stant decrease in milk yield and 
milk quality. In addition, micro-
organisms become accustomed 
to common antimicrobials and 
lead to antibiotic resistance [5]. 
Although somatic cell count is 
widely used to diagnose udder 
health, it can be affected by many 
factors. Therefore, to improve the 
accuracy of diagnosis of mastitis, 
integrated approaches are used, 
for example, a combination of 
California test for mastitis, the 
pH value of milk, enzyme test [6]. 
It should be noted that studies 
have shown that the microflora of 
the gastrointestinal tract plays an 
important role in inflammation 
of tissues outside the intestine, such as the breast. Dysbacterio-
sis of the microbiota of the gastrointestinal tract may be one of 
the causes of mastitis [7]. Probiotics can penetrate the intestinal 
epithelium and reach the udder tissue through the bloodstream, 
acting as an effective booster of immunity [8]. Scientists in their 
studies have suggested the link between the environment of the 
gastrointestinal tract and the health of the breast [9].
Taking into account the previous researches of scientists, the 
method of treatment of subclinical mastitis with the use of probi-
otic bacterial strain – Bacillus megaterium is proposed in the work. 
The aim of the research. To determine the effect of Bacil-
lus megaterium on the microflora of the gastrointestinal tract 
and colonies of microorganisms 
isolated from subclinical mastitis 
in cows.
2. Materials and methods 
The research was conducted in 
the dairy farm of Ukraine on the 
cultivation of Holstein. Cows with 
subclinical mastitis of the experi-
mental groups were given concen-
trated feed with the addition of Ba-
cillus megaterium (1×109 CFU/g) 
at a dose of 15–35 g per animal. In 
each experimental group and con-
trol there were 10 animals of the 
Holstein breed. In the first group 
(1D) to the daily diet was added 
15 g, in the second (2D) – 25 g and 
in the third (3D) – 35 g of Bacil-
lus megaterium (1×109 CFU/g) per 
animal. The control group (C) of 
healthy cows was given the usual 
diet for dairy cows. The experi-
ment lasted 30 days.
All research activities on 
cattle were performed taking 
into account Directive 2010/63/
EU and clarifications made by 
Regulation (EU) 2019/1010 and 
approved by the conclusion of 
the Commission on Ethics and 
Bioethics of the Faculty of Veter-
inary Medicine of Sumy Nation-
al Agrarian University Protocol 
No. 6 from 11.10. 2021.
A California test [10] and mi-
croscopy to count the number 
of somatic cells [11] were used 
to study dairy cows for mastitis. 
The quantity of mesophilic aero-
bic and facultative anaerobic mi-
croorganisms (QMAFAnM) was 
determined in accordance with 
DSTU 7357, DSTU 7089, DSTU 
ISO 4833, DSTU IDF 100B.
The calculation of the experi-
mental results was performed us-
ing the program Microsoft Excel 
for Windows 2010. The obtained 
data were statistically calculated 
by the Fisher-Student method, 
taking into account statistical er-
rors and probabilities of more than 95 % (p<0.05). 
3. Results
In the farm, the problem of subclinical mastitis occurs im-
mediately after calving. According to the results of examination 
of cows with subclinical mastitis, it was found that they also 
have signs of scar hypotension, diarrhea and the onset of ketosis. 
Therefore, it was decided to carry out experimental treatment of 
dairy cows using Bacillus megaterium in different proportions 
together with the standard diet for dairy cows. The results of the 
effect of Bacillus megaterium on the microflora of the gastroin-
testinal tract of cows are presented in Fig. 1.
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Abstract: The problem of treatment of subclinical mastitis 
often arises after calving, especially in cows of the first lacta-
tion. The paper presents the results of the therapeutic effect 
of Bacillus megaterium in subclinical mastitis in cows. 
The aim of the research. To determine the effect of Bacillus 
megaterium on the microflora of the gastrointestinal tract 
and colonies of microorganisms isolated from subclinical 
mastitis in cows.
Materials and methods. The research was conducted in a 
dairy farm growing Holstein. Cows with subclinical mastitis 
of the experimental groups were given concentrated feed with 
the addition of Bacillus megaterium (1×109 CFU/g) at a dose of 
15–35 g per animal. The control group of cows was given the 
usual diet for dairy cows. The experiment lasted 30 days.
Results. The use of Bacillus megaterium (1×109 CFU/g) at a 
dose of 35 g per animal had a pronounced effect on the mi-
croflora of the gastrointestinal tract of cows. The amount of 
Lactobacillus sp. was 67 % higher and Bifidobacterium 58 % 
higher than the control. In addition, the level of oppor-
tunistic pathogens on Escherichia coli decreased by 45 %, 
Clostridium by 27 %, Enterobacteriaceae and Staphylococcus 
by 75 %, and Candida by 80 % compared to controls. The 
amount of microflora in milk decreased by 40.2 % and the 
number of somatic cells by 87.9 %.
Conclusions. The therapeutic efficacy of Bacillus megateri-
um (1×109 CFU/g) at a dose of 35 g per animal for 30 days 
in subclinical mastitis has been proven. After treatment, the 
amount of microflora in cow’s milk decreased by 40.2 % and 
the number of somatic cells by 87.9 %.
A positive effect on the microflora of the gastrointestinal tract 
of cows, where the number of Lactobacillus sp. increased by 
67 % and Bifidobacterium by 58 %. The level of opportunistic 
pathogenic microflora decreased by Escherichia coli – by 45 %, 
Clostridium – by 27 %, Enterobacteriaceae and Staphylococcus – 
by 75 %, Candida – by 80 %, compared to the control.
Keywords: cows, subclinical mastitis, gastrointestinal mi-
croflora, number of somatic cells.
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At a dose of 15 g Bacillus megaterium (1×109 CFU/g) con-
tributed to an increase in the number of Lactobacillus sp. by 
10 % and Bifidobacterium by 12 % compared to controls. There 
was no significant suppression of opportunistic pathogens.
Increasing the dose of Bacillus megaterium (1×109 CFU/g) 
to 25 g per animal had a positive effect on the microbiome of 
the gastrointestinal tract. The level of beneficial microflora 
increased Lactobacillus sp. was 35 % higher and Bifidobacteri-
um 30 % higher than the control. Suppression of opportunistic 
pathogens occurred rather slowly.
According to the results of the study, we can say that the 
maximum positive effect on the microflora of the gastro-
intestinal tract of cows had the use of Bacillus megaterium 
(1×109 CFU/g) at a dose of 35 g per animal. The amount of 
Lactobacillus sp. was 67 % higher and Bifidobacterium 58 % 
higher than the control. In addition, the level of opportunistic 
microflora of Escherichia coli decreased by 45 %, Clostridium by 
27 %, Enterobacteriaceae and Staphylococcus by 75 %, Candida 
by 80 % compared to the control.
To clarify the results and establish the therapeutic effect of 
Bacillus megaterium in subclinical mastitis of cows, milk studies 
were performed at the beginning and after the study (Table 1).
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1 D 90±1.36 73±1.25 934.2±123.4 621.5±132.9
2 D 85±1.28 67±1.35 925.7±113.8 386.9*±109.4*
3 D 92±1.45 55±1.40* 897.5±110.6 108.5±110.6*
Control 
group 50±1.18 52±1.20 76.8±5.6 75.4±4.9
Note: *– р≤0.05 compared to the beginning of the study. According to DSTU 
7357: 2013 “Milk and dairy products. Methods of microbiological control”
The use of Bacillus megaterium at a dose of 15 g (1 D) in 
animals for 30 days helped to reduce the microflora in milk by 
18 % and the number of somatic cells by – 33.5 % compared to 
the beginning of treatment.
Increasing the dose of Bacillus megaterium to 25 g (2 D) gave 
the cow a 21.2 % decrease in QMAFAnM and a 58.2 % decrease 
in NSC compared to the beginning of the study.
Return of milk to the extra class occurred when Bacillus me-
gaterium was administered to animals at a dose of 35 g (3 D) for a 
month. The amount of microflora in milk decreased by 40.2 % and 
the number of somatic cells by 87.9 %. An important result is the ef-
fective treatment of cows from subclinical mastitis without the use 
of antimicrobials, as well as the improvement of the microbiome.
4. Discussion of research results
Timely diagnosis and treatment of subclinical mastitis in cows 
is one of the important tasks of a veterinarian [12]. The return of 
dairy productivity and milk production to the extra class is very 
important for economic reasons for farmers, in which the profit-
ability of the enterprise depends directly on product quality [13].
The use of Bacillus megaterium (1×109 CFU/g) as a probiotic 
at a dose of 35 g per animal for 30 days helps to increase the 
amount of beneficial microflora and suppress opportunistic 
pathogens [14]. By improving the microbiome, immunity in ani-
mals is increased and milk productivity is restored [15]. Milk ob-
tained from recovered cows does not contain antibiotics and has 
a safe amount of microorganisms and somatic cells. Therefore, 
these products can be used without restrictions for consumers.
Study limitations. The limitation of the research is the 
small number of livestock involved in the research. 
Prospects for further research. The prospect of further 
research is to conduct large-scale production research on a sig-
nificant number of livestock.
5. Conclusions
The therapeutic efficacy of Bacillus megaterium (1×109 CFU/g) 
at a dose of 35 g per animal for 30 days in subclinical mastitis has 
been proven. After treatment, the amount of microflora in cow’s 
milk decreased by 40.2 % and the number of somatic cells by 
87.9 %.
A positive effect on the microflora of the gastrointestinal 
tract of cows, where the number of Lactobacillus sp. increased 
by 67 % and Bifidobacterium by 58 %. The level of opportunistic 
pathogenic microflora decreased by Escherichia coli – by 45 %, 
Clostridium – by 27 %, Enterobacteriaceae and Staphylococcus – 
by 75 %, Candida – by 80 %, compared to the control.
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Fig. 1. Influence of Bacillus megaterium on the formation of the 
microflora of the gastrointestinal tract of cows
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